Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.43 |
| ▸ | ATM | Q13315 | 1/20 | 0.43 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.34 |
| ▸ | HPGD | P15428 | 4/20 | 0.34 |
| ▸ | MEN1 | O00255 | 3/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.34 |
| ▸ | PTPN5 | P54829 | 1/20 | 0.34 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.33 |
| ▸ | PLA2G2A | P14555 | 2/20 | 0.33 |
| ▸ | PLA2G4A | P47712 | 2/20 | 0.33 |
| ▸ | MAPT | P10636 | 3/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24174744 | 1.00 | KDM4E (0.43) | KDM4EL3MBTL1ATMHDAC4ALDH1A1 | |
| SCHEMBL24676179 | 0.99 | KDM4E (0.41) | KDM4EL3MBTL1ATMHDAC4ALDH1A1 | |
| SCHEMBL24676321 | 0.99 | KDM4E (0.41) | KDM4EL3MBTL1ATMHDAC4ALDH1A1 | |
| SCHEMBL17246177 | 0.96 | KDM4E (0.47) | KDM4EL3MBTL1ATMALDH1A1SMN1; SMN2 | |
| SCHEMBL24676095 | 0.94 | KDM4E (0.44) | KDM4EL3MBTL1ATMALDH1A1SMN1; SMN2 | |
| SCHEMBL24675488 | 0.92 | ATM (0.41) | KDM4EL3MBTL1ATMHDAC4ALDH1A1 | |
| SCHEMBL24676227 | 0.92 | ATM (0.41) | KDM4EL3MBTL1ATMHDAC4ALDH1A1 | |
| SCHEMBL24676170 | 0.92 | ATM (0.41) | KDM4EL3MBTL1ATMHDAC4ALDH1A1 | |
| SCHEMBL24676612 | 0.92 | ATM (0.41) | KDM4EL3MBTL1ATMHDAC4ALDH1A1 | |
| SCHEMBL24174202 | 0.92 | KDM4E (0.38) | KDM4EL3MBTL1ATMHDAC4ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230309390-A1 | ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG ELECTRONICS CO LTD (KR) | 2023-09-28 | — | — | US | disclosed |
| US-20230033529-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO.,LTD. (JP) | 2023-02-02 | — | — | US | disclosed |
| US-20230027888-A1 | ORGANIC ELECTROLUMINESCENT DEVICE, ORGANIC ELECTROLUMINESCENCE DISPLAY DEVICE, ELECTRONIC DEVICE AND COMPOUND | IDEMITSU KOSAN CO.,LTD. (JP) | 2023-01-26 | — | — | US | disclosed |
| US-20220238815-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT, COMPOUND, AND ELECTRONIC APPLIANCE | IDEMITSU KOSAN CO.,LTD. (JP) | 2022-07-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230027888-A1 | ORGANIC ELECTROLUMINESCENT DEVICE, ORGANIC ELECTROLUMINESCENCE DISPLAY DEVICE, ELECTRONIC DEVICE AND COMPOUND | HTR1D, EHD1, HTR3D | KDM4E 3361/4885L3MBTL1 1030/4885ATM 3140/4885 |
| US-20230033529-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC DEVICE | LEF1, L1CAM, RAP1A | KDM4E 3096/4885L3MBTL1 173/4885ATM 2806/4885 |
| US-20230309390-A1 | ORGANIC LIGHT-EMITTING DEVICE | L1CAM, EML4, OR10J3 | KDM4E 2238/4885L3MBTL1 23/4885ATM 2243/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.